Bovine Somatotropin And Emerging Issues PDF Download

Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Bovine Somatotropin And Emerging Issues PDF full book. Access full book title Bovine Somatotropin And Emerging Issues by Milton C Hallberg. Download full books in PDF and EPUB format.

Bovine Somatotropin And Emerging Issues

Author: Milton C Hallberg
Publisher: CRC Press
ISBN: 0429709862
Category : Science
Languages : en
Pages : 289

Book Description
Bovine somatotropin, or bST, a growth hormone genetically engineered to increase milk production in dairy cows, highlights the controversial issues of biotechnology and its widespread use. Focusing on the problems inherent in new and radically different technologies, this book develops a methodology for examining bST and other biotechnological deve

Bovine Somatotropin And Emerging Issues

Author: Milton C Hallberg
Publisher: CRC Press
ISBN: 0429709862
Category : Science
Languages : en
Pages : 289

Science and Social Context

Author: Lisa N. Mills
Publisher: McGill-Queen's Press - MQUP
ISBN: 0773570276
Category : Science
Languages : en
Pages : 222

Book Description
She examines the decision-making processes at Monsanto that led to their making the drug available and discusses corporate, academic, and regulatory decision-making in the context of a restructured global political economy for agriculture. Mills shows that there was consensus about the scientific evidence but interpretation of that evidence differed depending on the context from which it was viewed. Scientists who analysed it for regulatory bodies interpreted it differently than scientists in corporate or academic institutions, and scientists in Canada and Europe interpreted it differently than those in the United States. In the United States it was assumed that any problems arising from its use could be taken care of within the existing dairy system; in Canada and Europe these problems were regarded as legitimate animal welfare issues. While all regulatory bodies agreed that human health problems were unlikely, in Canada the Health Protection Branch questioned this, but ultimately rejected the drug on animal health grounds.